01 27Gilead Sciences Canada Inc.
02 2Merck Canada Inc.
01 12075189
02 12101572
03 22104399
04 22105486
05 52261619
06 12279198
07 52298059
08 12398887
09 12452217
10 12470365
11 22512475
12 12537095
13 12566922
14 12678907
15 12720856
16 12794377
17 12847871
18 13006192
01 2DORAVIRINE | LAMIVUDINE | TENOFOVIR DISOPROXIL FUMARATE
02 8Efavirenz | Emtricitabine | Tenofovir Disoproxil Fumarate
03 7Elvitegravir | Cobicistat | Emtricitabine | Tenofovir disoproxil fumarate
04 3Emtricitabine | Tenofovir Disoproxil Fumarate
05 2Tenofovir Disoproxil Fumarate
06 7tenofovir disoproxil fumarate | emtricitabine | rilpivirine
01 2TABLET
02 20Tablet
03 7Tablets
01 12011-01-31
02 22012-02-20
03 22012-03-05
04 12013-07-29
05 52017-07-25
06 12018-02-02
07 52018-07-23
08 12021-02-26
09 12022-08-09
10 12023-11-20
11 22024-01-13
12 12024-09-03
13 12025-05-19
14 12026-12-29
15 12028-02-22
16 12029-05-01
17 12031-03-28
18 12036-11-29
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2512475
Filing Date : 2004-01-13
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2075189
Filing Date : 1991-01-31
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-01-31
Date Granted : 2004-11-30
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2101572
Filing Date : 1993-07-29
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-07-29
Date Granted : 2001-08-28
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2104399
Filing Date : 1992-02-20
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-20
Date Granted : 2005-10-18
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2105486
Filing Date : 1992-03-05
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-03-05
Date Granted : 2003-10-28
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : ATRIPLA
Patent Number : 2512475
Filing Date : 2004-01-13
Strength per Unit : 600mg, 200mg, 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-01-13
Date Granted : 2009-06-02
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Emtricitabine, Tenofovir Disoproxil Fumarate
Brand Name : TRUVADA
Patent Number : 2261619
Filing Date : 1997-07-25
Strength per Unit : 200mg / 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-07-25
Date Granted : 2006-05-23
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
Brand Name : VIREAD
Patent Number : 2298059
Filing Date : 1998-07-23
Strength per Unit : 300mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-23
Date Granted : 2008-12-30
